Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
Authors:
- 1 October 1991
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 18 (4) , 558-563
Abstract
We studied whether inhibition of angiotensin converting enzyme stimulates the formation of nitric oxide and prostacyclin in cultured human and bovine endothelial cells by an enhanced accumulation of endothelium-derived bradykinin. Nitric oxide formation was assessed in terms of intracellular cyclic GMP accumulation, prostacyclin release by a specific radioimmunoassay. Inhibition of angiotensin converting enzyme by ramiprilat dose- and time-dependently increased the formation of nitric oxide and prostacyclin. These increases, peaking within 10 minutes, were maintained for at least 60 minutes. The ramiprilat-induced cyclic GMP increase was completely abolished by the stereospecific inhibitor of nitric oxide synthase, NG-nitro-L-arginine. The B2-kinin receptor antagonist, Hoe 140 (0.1 microM), markedly attenuated the cyclic GMP accumulation and abolished the increase in prostacyclin release. The supernatant of endothelial cells, incubated with ramiprilat (0.3 microM) for 15 minutes, elicited a significant nitric oxide release (as assessed by a guanylyl cyclase assay) in untreated endothelial cells used as detector tissue. Preincubation of the detector cells with Hoe 140 completely abolished this nitric oxide release. These data indicate that cultured endothelial cells from different species are capable of producing and releasing bradykinin into the extracellular space in amounts that lead to a sustained stimulation of nitric oxide and prostacyclin formation, provided that bradykinin degradation is prevented by angiotensin converting enzyme inhibition. Thus, the protective effect of angiotensin converting enzyme inhibitors observed on endothelial vasomotor function in hypertension may be explained by the local accumulation of endothelium-derived bradykinin that acts in an autocrine and paracrine manner as potent stimulus for endothelial autacoid formation.Keywords
This publication has 22 references indexed in Scilit:
- Does antihypertensive therapy improve the function of the vascular endothelium?Hypertension, 1990
- Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats.Hypertension, 1990
- Kinin- and Non-Kinin-Mediated Interactions of Converting Enzyme Inhibitors with Vasoactive HormonesJournal of Cardiovascular Pharmacology, 1990
- Hemodynamic Effects of Bradykinin on Systemic and Pulmonary Circulation in Healthy and Hypertensive HumansJournal of Cardiovascular Pharmacology, 1990
- Some Old and Some New Ideas on Kinin MetabolismJournal of Cardiovascular Pharmacology, 1990
- Role of Kallikrein-Kinin System in the Hypotensive Mechanisms of Converting Enzyme Inhibitors in Essential HypertensionJournal of Cardiovascular Pharmacology, 1989
- Characterization of vascular relaxant factor released from cultured endothelial cells.Hypertension, 1987
- Induction of prostacyclin biosynthesis is closely associated with increased guanosine 3',5'-cyclic monophosphate accumulation in cultured human endothelium.Journal of Clinical Investigation, 1986
- Converting enzyme inhibitor ramipril stimulates prostacyclin synthesis by isolated rat aorta: Evidence for a kinin-dependent mechanismJournal of Molecular Medicine, 1986
- Renin- and non-renin–mediated antihypertensive actions of converting enzyme inhibitorsKidney International, 1984